MarketsandMarkets

Point-of-Care Diagnostic Market (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers) Worth $27.5 Billion by 2018

Point-Of-Care Diagnostics Market report categories the Global market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018

 
Repost This

Dallas, TX -- (SBWIRE) -- 04/09/2014 -- The report “Point-Of-Care Diagnostic Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018”, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Asia-Pacific, Europe, and the Rest of the World.

Browse 198 market data tables and 48 figures spread through 452 pages and in-depth TOC on “Point-Of-Care Diagnostic Market”.
http://www.marketsandmarkets.com/Market-Reports/point-of-care-diagnostic-market-106829185.html
Early buyers will receive 10% customization on this report.

The global point-of-care diagnostics market is expected to reach $27.5 billion by 2018, at a CAGR of 9.3% from 2013 to 2018.

Download Free PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=106829185

A number of factors such as the rising prevalence of lifestyle and infectious diseases, increasing usage of home-based POC devices, and decreasing number of technicians in central labs are driving the growth of the global market. Furthermore, growing government support and increasing private investments and venture funding to support new product development are other factors that are propelling the growth of the market. In addition, rising adoption of POC devices, expansion of therapeutic horizon, and technological advancements is further fueling the growth of this market.

Inquiry Before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=106829185

However, a few pivotal factors such as lack of alignment with definitive central lab methods, and reluctance to change existing treatment practices are hindering the growth of this market. Moreover, disadvantages of POC testing over central lab methods and recalls of leading glucose monitoring devices are the foremost challenges faced by industry players.

The global point-of-care diagnostics market is dominated by North America, followed by Europe, Asia-Pacific and the Rest of the World (RoW). North America will continue to dominate the market in the forecast period, followed by the Asia-Pacific. However, the Asia-Pacific region is expected to grow at the highest CAGR of ~13.6% from 2013 to 2018. Over the next five years, the growth of the market in the Asia-Pacific region is likely to be centered at Japan, China, and India. A number of factors such as the huge patient population base, increasing funding/investment toward the development of point of care diagnosticproducts, growing focus of both international and domestic players on the Asia-Pacific point-of-care diagnostics market, and large number of R&D activities are driving the growth of the market in the Asia-Pacific region.

The market is a diversified and competitive market, with a large number of players. The market (excluding blood glucose monitoring kits market) is dominated by various players, depending on their core competencies. The key players in this market are Roche Diagnostics Ltd. (Switzerland), Alere Inc. (U.S.), Siemens AG (Germany), and Beckman Coulter, Inc. (U.S.). Whereas, the key players in the global blood glucose monitoring kits market are Roche Diagnostics Limited (Switzerland), Johnson & Johnson (U.S.), Bayer AG (Germany), and Abbott Laboratories (U.S.).

Browse related reports:
Diagnostic Imaging Market by X-ray Systems (Digital, Analog, Portable), Computed Tomography, Ultrasound Imaging Systems (2D, 3D, 4D, Doppler), MRI Machines (Closed & Open), and Nuclear Imaging Systems (SPECT, PET, PET/CT) - Global Forecasts to 2018
http://www.marketsandmarkets.com/Market-Reports/diagnostic-imaging-market-411.html

Global Nuclear Imaging Systems / Equipment Market (2011 - 2016) - PET (Positron Emission Tomography) & SPECT (Single Photon Emission Computed Tomography) Landscape
http://www.marketsandmarkets.com/Market-Reports/pet-market-98.html

About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com/market-reports/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets